Meanwhile, elevated expression of DDX49 was found in patients with recurrent PCa compared with patients who were free of recurrence (24.32 ± 7.14 vs. 22.02 ± 6.52, p = 0.008), indicating that DDX49 may be involved in the biochemical recurrence of PCa. Here, DDX49 is linked to posterior cortical atrophy.